Dogs Use Soundboards to Intentionally Communicate, New Study Reveals

/in /tarafından

Study Highlights Canine Communication Through Soundboards
A groundbreaking study by the Comparative Cognition Lab at the University of California, San Diego, has provided new insights into dogs’ ability to communicate intentionally using soundboards. Published in Scientific Reports, the research analyzed data collected from 152 dogs over a 21-month period. Researchers observed that trained dogs were able to form meaningful two-word combinations, moving beyond random button pressing or imitative behavior. Over 260,000 button presses were recorded during the study, with 195,000 of these presses attributed to intentional actions by the dogs.

Evidence of Purposeful Communication
The study revealed that dogs most frequently used buttons tied to their basic needs. Words such as “outside,” “play,” “treat,” and “potty” dominated the interactions. For instance, combinations like “outside” + “potty” were used in contexts that matched their meaning, demonstrating a clear intent to communicate specific desires. Dr. Federico Rossano, Associate Professor of Cognitive Science and the study’s lead author, emphasized that these behaviors suggest deliberate decision-making rather than mere coincidence or mimicry.

Technology as a Bridge Between Species
The use of soundboards opens up new possibilities for human-canine communication. By pressing buttons that correspond to words, dogs can convey their needs and preferences with greater clarity. Dr. Rossano highlighted the potential of this technology to reduce misunderstandings and frustration between pets and their owners. For example, instead of barking ambiguously, a dog could press “outside” and “park” to indicate a desire for a walk in a specific location.

Strengthening Human-Animal Bonds
The implications of the study extend beyond mere novelty, offering a glimpse into how technology can deepen the relationship between humans and their canine companions. As dogs gain a more precise method of expression, owners are better equipped to understand and respond to their pets’ needs. This enhanced communication could lead to improved quality of life for both dogs and their humans, fostering a stronger bond built on mutual understanding.

AI’s Groundbreaking Contributions to Science in 2024

/in /tarafından

In 2024, artificial intelligence (AI) reached a milestone, solidifying its role as a transformative tool in scientific research. The Nobel committee acknowledged AI’s impact by awarding the physics prize to John Hopfield and Geoffrey Hinton for their pioneering work in machine learning, which laid the foundation for modern AI applications. AI’s contributions this year have been far-reaching, from unlocking ancient texts to advancing our understanding of life at its most molecular level.

One of the most notable AI-assisted breakthroughs was in the decoding of the Herculaneum scrolls, ancient papyri that survived the eruption of Mount Vesuvius in AD 79. With the help of AI and high-resolution X-rays, researchers have now been able to decipher more than 2,000 characters from these nearly unreadable scrolls. The Vesuvius Challenge, a competition to expedite the deciphering process, has set a goal to unlock 90% of the scrolls by the end of 2024. AI’s ability to virtually flatten the charred scrolls and distinguish ink from carbonized papyri has made this remarkable feat possible, offering unprecedented insights into ancient Rome and Greece.

Another area where AI is making waves is in the study of animal communication. Machine learning has enabled scientists to begin understanding the complex “language” of sperm whales. By analyzing 9,000 click sequences, researchers have identified patterns that resemble human phonetics, such as rhythm, tempo, and ornamentation. While the meaning of these clicks remains elusive, AI’s ability to detect these intricate patterns is opening the door to potential communication with marine mammals. The same techniques are being applied to other species, offering a new way to understand animal languages.

In the field of archaeology, AI is helping to uncover ancient sites in remote and challenging environments. In the Nazca Desert, AI models trained on high-resolution imagery have nearly doubled the number of known geoglyphs in just a few months. While the models are not yet perfect, they hold immense potential for surveying hard-to-reach areas, making AI an indispensable tool for archaeologists. Similarly, AI is aiding in the identification of burial mounds in Mongolia, demonstrating its utility in archaeological research across diverse terrains.

AI is also revolutionizing the understanding of life at the molecular level. The development of AlphaFold by Google DeepMind has accelerated progress in protein structure prediction, solving a long-standing challenge in physical chemistry. This AI tool, now used by millions of researchers, predicts the 3D shapes of proteins from their amino acid sequences, speeding up advancements in biology and medicine. While there are limitations—such as the inability to predict the impact of certain mutations—AlphaFold remains a game-changer in biomedical research.

These examples reflect the growing influence of AI in scientific discovery. From unraveling ancient mysteries to decoding the language of animals and advancing medical research, AI is proving to be a superpower in science. As the field continues to evolve, its potential to solve complex problems and uncover the unknown remains boundless.

Merck Signs $2 Billion Licensing Deal for Weight Loss Pill with Chinese Drugmaker Hansoh Pharma

/in /tarafından

Merck announced on Wednesday that it has secured the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma in a deal worth up to $2 billion. This oral drug, currently not in human trials, could position Merck to capitalize on the rapidly expanding obesity drug market, which analysts predict could exceed $100 billion annually by the early 2030s.

While Merck did not specify the diseases it plans to target first with this drug, the deal significantly boosts its potential in the obesity treatment field. The move comes as several other pharmaceutical companies, including Pfizer and Roche, are working to develop competitive oral weight loss medications that can challenge the blockbuster injectable drugs from Novo Nordisk and Eli Lilly.

Under the terms of the agreement, Merck will receive exclusive global rights to develop, manufacture, and commercialize Hansoh Pharma’s HS-10535, an oral drug targeting GLP-1, a gut hormone. GLP-1 is the same target for Novo Nordisk’s popular weight loss drug Wegovy and diabetes medication Ozempic, which work by suppressing appetite and regulating blood sugar levels.

Merck will pay Hansoh Pharma an upfront fee of $112 million for the licensing rights to the drug. Additionally, the deal includes up to $1.9 billion in milestone payments and royalties on future sales, according to a press release from the company.

Merck’s president of Research Laboratories, Dean Li, expressed confidence in the drug’s potential, noting it could offer “additional cardiometabolic benefits beyond weight reduction.” The company has been actively seeking GLP-1 treatments that provide not just weight loss but other health benefits, such as improvements in cardiovascular health, diabetes, and fatty liver disease. Merck CEO Rob Davis highlighted this strategic focus in early 2023, stating that therapies with broader health benefits would be crucial for obtaining reimbursement and establishing long-term market success.

This agreement with Hansoh Pharma adds to the growing trend of Chinese companies entering the global market for GLP-1-based treatments. In a similar deal last year, AstraZeneca licensed an experimental oral GLP-1 drug from Chinese company Eccogene, which is currently in mid-stage development.